Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,963,113
-
Share change
-
+749,712
-
Total reported value
-
$18,730,000
-
Price per share
-
$3.15
-
Number of holders
-
26
-
Value change
-
+$2,766,566
-
Number of buys
-
14
-
Number of sells
-
7
Institutional Holders of TRACON PHARMACEUTICALS INC - COM (TCON) as of Q3 2017
As of 30 Sep 2017,
TRACON PHARMACEUTICALS INC - COM (TCON) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,963,113 shares.
The largest 10 holders included
NEA Management Company, LLC, 683 Capital Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, QVT Financial LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Candriam Luxembourg S.C.A., Alyeska Investment Group, L.P., RAYMOND JAMES & ASSOCIATES, and BlackRock Inc..
This page lists
26
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.